Related Experiment Video
Updated: Aug 6, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
CTLA-4 Gene Polymorphism in Pediatric Type 1 Diabetes Mellitus: A Case-Control Study
Thammineni Aniketh1, Raghavendra Gobbur1, Gurushantappa S Kadakol2
1Department of Pediatrics, Shri B. M. Patil Medical College and Hospital and Research Center, BLDE (Deemed to be University), Vijayapura, Karnataka, India.
Objective:
To analyze the relationship between CTLA-4 (+49A/G) polymorphism and pediatric type 1 diabetes mellitus (T1DM).
Materials And Methods:
The observational case-control study was done for 18 months in 44 children (1-16 years of age), 22 of whom had T1DM and 22 controls, were included. CTLA-4 (+49A/G) gene polymorphism was analyzed using polymerase chain reaction-restriction fragment length polymorphism and validated by Sanger sequencing. Various clinical, anthropometric, and biochemistry variables were documented.
Results:
The cases and controls were similar in terms of age, gender distribution, family history of diabetes, and consanguinity. The average hemoglobin A1c values were higher in case groups compared to controls (12.41% ±3.09% vs. 4.21 ± 0.5%; P < 0.001). The CTLA4 (+49A/G) gene showed higher frequencies of the G/G genotype in cases compared to controls (54.55% vs. 22.73%; P = 0.030), whereas A/A was found to be higher in controls (P = 0.014). The frequency of the G allele in cases (0.66) was higher than in controls (0.32). The G/G genotype showed higher prevalence in the case group at a younger age, and siblings of offspring showed clustering of the G/G genotype.
Conclusion:
In particular, the G/G genotype of the CTLA-4 + 49A/G polymorphism was found to be significantly associated with T1DM in children and to influence the age of onset.
Related Concept Videos
Type I Diabetes I: Introduction
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
